PRTN3 and rheumatoid arthritis: Notably, two of the three anti-MAA clones isolated from the lung tissues were derived from ACPA+ at risk RA patients (study participants without signs or symptoms of RA), suggesting that the lung may serve as an early site of autoantibody production, before the onset of clinical RA.